发明公开
EP1258245A2 Accelerated release composition containing bromocriptine
失效
Bromocriptin enthaltende Zusammensetzung mit beschleunigter Freisetzung
- 专利标题： Accelerated release composition containing bromocriptine
- 专利标题（中）： Bromocriptin enthaltende Zusammensetzung mit beschleunigter Freisetzung
-
申请号： EP02018888.4申请日： 1994-12-22
-
公开(公告)号： EP1258245A2公开(公告)日： 2002-11-20
- 发明人: Cincotta, Anthony N. , Tigner, Susan Louise , Pelloni, Christopher Louis , Cincotta, Manuel, Jr. , Runice, Christopher Eric
- 申请人： ERGO SCIENCE INCORPORATED , GENEVA PHARMACEUTICALS, INC.
- 申请人地址： Charlestown Navy Yard, 100 First Avenue,Fourth Floor Charlestown, MA 02129-2051 US
- 专利权人： ERGO SCIENCE INCORPORATED,GENEVA PHARMACEUTICALS, INC.
- 当前专利权人： ERGO SCIENCE INCORPORATED,GENEVA PHARMACEUTICALS, INC.
- 当前专利权人地址： Charlestown Navy Yard, 100 First Avenue,Fourth Floor Charlestown, MA 02129-2051 US
- 代理机构： Vossius, Volker, Dr.
- 优先权： US171897 19931222
- 主分类号： A61K31/48
- IPC分类号： A61K31/48 ; A61K9/20 ; A61P5/08
摘要：
Disclosed herein is a solid oral dosage form comprising bromocriptine and one or more pharmaceutically acceptable excipients. The oral dosage form has a dissolution rate in excess of 90% in 5 minutes in 500 ml of 0.1N HCl aqueous medium at 37°C and is useful for adjusting the plasma prolactin profile of a patient.
公开/授权文献
- EP1258245A3 Accelerated release composition containing bromocriptine 公开/授权日：2003-01-02
信息查询
IPC分类:
